Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 88
Filtrar
Mais filtros

Intervalo de ano de publicação
2.
Med Care ; 59(Suppl 3): S252-S258, 2021 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-33976074

RESUMO

BACKGROUND: Congress has enacted 2 major pieces of legislation to improve access to care for Veterans within the Department of Veterans Affairs (VA). As a result, the VA has undergone a major transformation in the way that care is delivered to Veterans with an increased reliance on community-based provider networks. No studies have examined the relationship between VA and contracted community providers. This study examines VA facility directors' perspectives on their successes and challenges building relationships with community providers within the VA Community Care Network (CCN). OBJECTIVES: To understand who VA facilities partner with for community care, highlight areas of greatest need for partnerships in various regions, and identify challenges of working with community providers in the new CCN contract. RESEARCH DESIGN: We conducted a national survey with VA facility directors to explore needs, challenges, and expectations with the CCN. RESULTS: The most common care referred to community providers included physical therapy, chiropractic, orthopedic, ophthalmology, and acupuncture. Open-ended responses focused on 3 topics: (1) Challenges in working with community providers, (2) Strategies to maintain strong relationships with community providers, and (3) Re-engagement with community providers who no longer provide care for Veterans. CONCLUSIONS: VA faces challenges engaging with community providers given problems with timely reimbursement of community providers, low (Medicare) reimbursement rates, and confusing VA rules related to prior authorizations and bundled services. It will be critical to identify strategies to successfully initiate and sustain relationships with community providers.


Assuntos
Serviços de Saúde Comunitária/organização & administração , Redes Comunitárias/organização & administração , Pessoal de Saúde/psicologia , Política de Saúde , Parcerias Público-Privadas/organização & administração , Serviços de Saúde Comunitária/legislação & jurisprudência , Redes Comunitárias/legislação & jurisprudência , Pesquisas sobre Atenção à Saúde , Pessoal de Saúde/organização & administração , Acessibilidade aos Serviços de Saúde/legislação & jurisprudência , Acessibilidade aos Serviços de Saúde/organização & administração , Humanos , Avaliação das Necessidades , Parcerias Público-Privadas/legislação & jurisprudência , Pesquisa Qualitativa , Estados Unidos , United States Department of Veterans Affairs/legislação & jurisprudência , Serviços de Saúde para Veteranos Militares/legislação & jurisprudência
3.
Harm Reduct J ; 17(1): 3, 2020 01 08.
Artigo em Inglês | MEDLINE | ID: mdl-31915012

RESUMO

BACKGROUND: Policy development by partnership is difficult, however, 'Reducing Harm, Supporting Recovery- A health led response to drug and alcohol use in Ireland 2017-2025' hailed a new era. This policy was based on an agreed philosophy and core values across a 21-member partnership and has stated a common commitment to a health-led response. METHODS: To drive strategy development, a cross-discipline committee with an independent Chair was created by the Minister. Members came from statutory, voluntary, community, research and service-user organisations. A consensus-based, partnership approach was taken to developing the policy and the action plan. Over 18 months of debate, a public consultation, focus groups, evidence reviews and an external expert review were conducted. Evidence was reviewed by the committee and following a very robust debate, a set of priority actions and responsible organisations were established. RESULTS: Nineteen meetings were held. Epidemiological indicators illustrated that cannabis use, young people, chronic opiate use, mortality and geography were a priority. Almost 3000 individuals/organisations responded to the public consultation and themes arising were, supply-reduction, prevention, treatment, rehabilitation and research. The evidence review found that evidence was weak or lacking. The focus groups addressed priorities in supply, education, prevention, continuum of care, evidence and best practice. Finally, the expert review examined structures. Significant contentious debate arose around the initial terms of reference and the authority of a member to agree to an action on behalf of a ministry. While not all members were fully satisfied with the strategy, all welcomed the commitment to the health-led approach. An implementation committee was established, a tender for the first medically supervised injecting facility was issued and a sub-committee to explore decriminalisation was formed. CONCLUSION: A key recommendation from the process was to ensure that all voices had an equal opportunity to be heard and to ensure that priority actions identified from the wider sources of evidence were not lost during the extended process. The breath of the partnership aided this. While we have succeeded in developing a sound strategy, success will depend on continuing support from the partnership and appropriate resourcing from the ministries.


Assuntos
Redução do Dano , Avaliação de Programas e Projetos de Saúde/métodos , Parcerias Público-Privadas/legislação & jurisprudência , Transtornos Relacionados ao Uso de Substâncias/prevenção & controle , Transtornos Relacionados ao Uso de Substâncias/terapia , Humanos , Irlanda
4.
Value Health ; 22(7): 754-761, 2019 07.
Artigo em Inglês | MEDLINE | ID: mdl-31277820

RESUMO

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a key venue for members from private industry, government, and academia to collaborate and share advances in regulatory, clinical, and reimbursement science for drugs, devices, and diagnostics. In parallel, the US Food and Drug Administration (FDA) "is responsible for advancing the public health by helping to speed innovations that make medical products more effective, safer, and more affordable." In 2012, the Medical Device Innovation Consortium (MDIC) was formed as a public-private partnership bringing together government, industry, and nonprofit organizations to advance approaches that promote patient access to safe, innovative medical technologies. With a focus on regulatory science, the MDIC has been assessing how to apply real-world evidence (RWE) regulatory science to medical devices. A key goal of this project is to review the history of RWE regulatory science, define terms, and explain why and how RWE is being considered across the total product life cycle, including regulatory assessment. Unique considerations of real-world data for in vitro diagnostics are also taken into account. We envision that these activities will help ensure a high level of rigor and integrity of RWE necessary for regulatory use cases and demonstrate where RWE can be successfully used for regulatory decision making. The ISPOR, FDA, and MDIC are providing the needed leadership in ensuring that diverse stakeholders share a meaningful voice in determining RWE use and, by so doing, are improving the quality and efficiency of care, enhancing health outcomes, and addressing broader societal concerns of reducing health disparities and costs.


Assuntos
Aprovação de Equipamentos/legislação & jurisprudência , Equipamentos e Provisões , Medicina Baseada em Evidências/legislação & jurisprudência , Política de Saúde/legislação & jurisprudência , Segurança do Paciente/legislação & jurisprudência , Formulação de Políticas , United States Food and Drug Administration/legislação & jurisprudência , Segurança de Equipamentos , Equipamentos e Provisões/efeitos adversos , Regulamentação Governamental , Humanos , Comunicação Interdisciplinar , Cooperação Internacional/legislação & jurisprudência , Vigilância de Produtos Comercializados , Parcerias Público-Privadas/legislação & jurisprudência , Medição de Risco , Terminologia como Assunto , Estados Unidos
5.
Rev Epidemiol Sante Publique ; 67 Suppl 1: S13-S18, 2019 Feb.
Artigo em Francês | MEDLINE | ID: mdl-30616880

RESUMO

In recent years, there has been a new institutional set of developments in France aimed at promoting the adoption of partnership-based, cross-sectoral and modulated health policies based on the health status of the population. Nevertheless, because addressing the challenge of health equity depends largely on the mobilization of a large number of protagonists with very heterogeneous initiatives, interests and values, the conduct of such policies potentially opens up a space for confrontation between those who wish to promote it and those who refuse, challenge, circumvent or neutralize the reconfigurations of public action and the work routines it inevitably induces. This company can therefore be marked by tensions and additional constraints for the actors. In this context, it remains largely conditional.


Assuntos
Equidade em Saúde/organização & administração , Promoção da Saúde/organização & administração , Disparidades nos Níveis de Saúde , Colaboração Intersetorial , Equidade em Saúde/legislação & jurisprudência , Equidade em Saúde/normas , Política de Saúde , Promoção da Saúde/legislação & jurisprudência , Promoção da Saúde/normas , Acessibilidade aos Serviços de Saúde/legislação & jurisprudência , Acessibilidade aos Serviços de Saúde/organização & administração , Acessibilidade aos Serviços de Saúde/normas , Humanos , Governo Local , Parcerias Público-Privadas/legislação & jurisprudência , Parcerias Público-Privadas/organização & administração , Parcerias Público-Privadas/normas , Erro Científico Experimental
6.
Duke Law J ; 68(7): 1433-68, 2019 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-30995705

RESUMO

Lost in the cacophony surrounding the debate about high drug prices is the fundamental principle that pharmaceutical innovation will not occur without the prospect of outsized returns enabled through market exclusivity. Biopharmaceutical patents are currently under siege, subject to challenge both in inter partes review ("IPR") proceedings and in Hatch-Waxman actions. These twin assaults threaten to eliminate the incentives necessary for biotechnological innovation--particularly for discoveries made upstream in the innovation pipeline--thus imperiling the development of new drug therapies. But a fascinating solution has emerged: invoking tribal immunity to shield pharmaceutical patents from IPR before the Patent Trial and Appeal Board ("PTAB"). This serves two critically important objectives: promoting tribal self-sufficiency, and encouraging investment in life-saving and life-improving new drugs. Contractual partnerships between Native American tribes and pharmaceutical companies not only provide the tribes with a steady stream of royalty revenue, but also insulate biopharmaceutical patents from challenge in IPR proceedings through the invocation of long-established principles of tribal sovereign immunity. This Note is the first piece of scholarship to comprehensively analyze, and advocate for, the right to invoke tribal sovereign immunity in IPR proceedings.


Assuntos
Desenvolvimento de Medicamentos/legislação & jurisprudência , Indústria Farmacêutica/legislação & jurisprudência , Indígenas Norte-Americanos/legislação & jurisprudência , Legislação de Medicamentos , Patentes como Assunto/legislação & jurisprudência , Comércio/legislação & jurisprudência , Humanos , Propriedade Intelectual , Parcerias Público-Privadas/legislação & jurisprudência , Estados Unidos
8.
J Intellect Disabil ; 21(3): 259-269, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28812964

RESUMO

The longevity of people with intellectual disabilities is increasing in developing nations. However, developing nations lack a proper system of care for aging persons with intellectual disabilities. Until now the care has been provided by parents and relatives in the home environment in developing countries, but this scenario is also changing; therefore, there is a strong need to explore a plan of care for this population which is also feasible and replicable. The National Trust is an autonomous body of the Government of India which has developed a comprehensive plan of care for adults with intellectual disabilities. In this article, the National Trust is discussed using a socioecological model. The replicability and suitability of this model for other developing countries are discussed.


Assuntos
Serviços de Saúde , Deficiência Intelectual/terapia , Parcerias Público-Privadas/organização & administração , Adulto , Serviços de Saúde/legislação & jurisprudência , Humanos , Índia , Parcerias Público-Privadas/legislação & jurisprudência
9.
Prev Chronic Dis ; 12: E50, 2015 Apr 16.
Artigo em Inglês | MEDLINE | ID: mdl-25880769

RESUMO

INTRODUCTION: Joint use or shared use of public school facilities provides community access to facilities for varied purposes. We examined a nationally representative sample of school districts in the United States to identify characteristics associated with having a formal joint use agreement (JUA) and with the kinds of uses to which JUAs apply. METHODS: We analyzed data from the 2012 School Health Policies and Practices Study. The response rate for the module containing questions about formal JUAs was 60.1% (N = 630). We used multivariate logistic regression models to examine the adjusted odds of having a formal JUA and χ(2) analyses to examine differences in district characteristics associated with the uses of the JUA. RESULTS: Among the 61.6% of school districts with a formal JUA, more than 80% had an agreement for the use of indoor and outdoor recreation facilities; other uses also were identified. JUAs were more common in urban than rural areas, in large than small school districts, and in the West compared with the Midwest, South, and Northeast. CONCLUSION: In many districts, school facilities appear to be an untapped resource for community members. Formal JUAs provide an opportunity for shared use while addressing issues of liability, cost, and logistics.


Assuntos
Serviços Contratados/estatística & dados numéricos , Política de Saúde , Parcerias Público-Privadas/estatística & dados numéricos , Serviços de Saúde Escolar/legislação & jurisprudência , Instituições Acadêmicas/organização & administração , Pessoal Administrativo/psicologia , Adolescente , Estudos de Casos e Controles , Centers for Disease Control and Prevention, U.S. , Criança , Pré-Escolar , Serviços Contratados/legislação & jurisprudência , Planejamento Ambiental , Etnicidade/estatística & dados numéricos , Financiamento Governamental , Serviços de Alimentação/economia , Serviços de Alimentação/legislação & jurisprudência , Serviços de Alimentação/estatística & dados numéricos , Humanos , Bibliotecas/estatística & dados numéricos , Modelos Logísticos , Avaliação de Resultados em Cuidados de Saúde , Logradouros Públicos/legislação & jurisprudência , Logradouros Públicos/estatística & dados numéricos , Parcerias Público-Privadas/economia , Parcerias Público-Privadas/legislação & jurisprudência , População Rural/estatística & dados numéricos , Gestão da Segurança , Serviços de Saúde Escolar/estatística & dados numéricos , Instituições Acadêmicas/economia , Instituições Acadêmicas/estatística & dados numéricos , Estudantes/estatística & dados numéricos , Inquéritos e Questionários , Estados Unidos , População Urbana/estatística & dados numéricos , Adulto Jovem
10.
Orv Hetil ; 156(11): 434-8, 2015 Mar.
Artigo em Húngaro | MEDLINE | ID: mdl-25749537

RESUMO

Reproductive human cloning is prohibited in Hungary, as in many other countries. Therapeutic human cloning is not prohibited, just like in many other countries. Stem cell therapy is also allowed. Article III, paragraph (3) of the Hungarian basic law (constitution) strictly forbids total human cloning. Article 1 of the Additional Protocol to the Oviedo Convention, on the Prohibition of Cloning Human Beings (1998) stipulates that any intervention seeking to create a human being genetically identical to another human being, whether living or dead, is prohibited. In Hungary, according to Article 174 of the Criminal Code, total human cloning constitutes a crime. Article 180, paragraph (3) of the Hungarian Act on Health declares that embryos shall not be brought about for research purposes; research shall be conducted only on embryos brought about for reproductive purposes when this is authorized by the persons entitled to decide upon its disposal, or when the embryo is damaged. Article 180, paragraph (5) of the Hungarian Act on Health stipulates that multiple individuals who genetically conform to one another shall not be brought about. According to Article 181, paragraph (1) of the Hungarian Act on Health, an embryo used for research shall be kept alive for not longer than 14 days, not counting the time it was frozen for storage and the time period of research.


Assuntos
Clonagem de Organismos/legislação & jurisprudência , Crime , Pesquisas com Embriões/legislação & jurisprudência , Pesquisa com Células-Tronco/legislação & jurisprudência , Argumento Refutável , Direito Penal , Humanos , Hungria , Parcerias Público-Privadas/ética , Parcerias Público-Privadas/legislação & jurisprudência , Fatores Socioeconômicos
11.
Stanford Law Rev ; 66(4): 873-952, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24834539

RESUMO

The Patient Protection and Affordable Care Act (ACA) transformed U.S. public law in crucial ways extending far beyond health care. As important as were the doctrinal shifts wrought by National Federation of Independent Business v. Sebelius, the ACA's structural changes to public law likely will prove far more important should they become entrenched. The struggle over the ACA has triggered the kind of "constitutional moment" that has largely replaced Article V's formal amendment procedure since the Prohibition fiasco. The Court participates in this process, but the definitive and enduring character of these constitutional moments' outcomes springs from broad popular engagement. Despite the Court's ruling and the outcome of the 2012 elections, the battle over whether to implement or shelve the ACA will continue unabated, both federally and in the states, until We the People render a clear decision. Whether the ACA survives or fails will determine the basic principles that guide the development of federalism, social insurance, tax policy, and privatization for decades to come. In each of these areas, the New Deal bequeathed us a delicate accommodation between traditionalist social values and modernizing norms of economic efficiency and interest group liberalism. This balance has come under increasing stress, with individual laws rejecting tradition far more emphatically than the New Deal did. But absent broad popular engagement, no definitive new principles could be established. The ACA's entrenchment would elevate technocratic norms across public law, the first change of our fundamental law since the civil rights revolution. The ACA's failure would rejuvenate individualistic, moralistic, pre-New Deal norms and allow opponents to attempt a counterrevolution against technocracy.


Assuntos
Constituição e Estatutos , Atenção à Saúde/legislação & jurisprudência , Regulamentação Governamental , Reforma dos Serviços de Saúde/legislação & jurisprudência , Política de Saúde/legislação & jurisprudência , Patient Protection and Affordable Care Act/legislação & jurisprudência , Privatização/legislação & jurisprudência , Política Pública/legislação & jurisprudência , Parcerias Público-Privadas/legislação & jurisprudência , Valores Sociais , Atenção à Saúde/tendências , Governo Federal , Previsões , Humanos , Política , Previdência Social/legislação & jurisprudência , Governo Estadual , Impostos/legislação & jurisprudência , Estados Unidos
12.
Encephale ; 40 Suppl 2: S57-65, 2014 Jun.
Artigo em Francês | MEDLINE | ID: mdl-24948479

RESUMO

This paper describes the role of social cooperatives in Italy as a type of economic, non-profit organization and their role in contributing to the economic and social growth of the country. The purpose of this paper is to learn more about the experience of the Italian social cooperatives in promoting the work integration process of disadvantaged workers, especially those suffering from mental disorders, from a theoretical and an empirical point of view. Social enterprise is the most popular and consolidated legal and organizational model for social enterprises in Italy, introduced by Law 381/91. Developed during the early 1980s, and formally recognized by law in the early 1990s, social cooperatives aim at pursuing the general interest of the community to promote the human needs and social inclusion of citizens. They are orientated towards aims that go beyond the interest of the business owners, the primary beneficiary of their activities is the community, or groups of disadvantaged people. In Italy, Law 381/91 distinguishes between two categories of social cooperatives, those producing goods of social utility, such as culture, welfare and educational services (A-type), and those providing economic activities for the integration of disadvantaged people into employment (B-type). The main purpose of B-type social cooperatives is to integrate disadvantaged people into the open labour market. This goal is reached after a period of training and working experience inside the firm, during which the staff works to improve both the social and professional abilities of disadvantaged people. During the years, B-type social co-ops acquired a particular relevance in the care of people with mental disorders by offering them with job opportunities. Having a job is central in the recovery process of people suffering from mental diseases, meaning that B-type social co-ops in Italy play an important rehabilitative and integrative role for this vulnerable population of workers. The recent literature has highlighted that difficulties with employment are a feature of mental disorders, with high unemployment rates and short job tenure. Yet, success in employment for this population can be expected when they are provided with adequate support and opportunities. B-type social cooperatives in Italy are found to be very useful in order to help this disadvantaged category of workers find and keep a job. The work environment is more flexible and allows a better integration with less stigma and better work accommodations compared to the open labour market and/or other public/private organizations. Results from B-type Italian social cooperatives studies show that mentally ill workers value the importance of working, are highly satisfied with their job, are motivated to continue working, are engaged in their job and willing to work in the competitive labour market. Also, studies show that environmental characteristics of the social cooperative, such as the implementation of work accommodations and the possibility to work in an environment that is highly supportive, have an impact on increasing the likelihood of being highly satisfied with the job, which in turn is positively related to job tenure. In sum, this article shed light on the historical background that led to the development of social cooperatives in Italy. Furthermore, the features of B-type co-ops that play a central role in facilitating the work integration of people with mental disorders are described in this paper. In general, Italian B-type social cooperatives are found to provide a meaningful work experience to people with mental disorders, that help them increase not only vocational outcomes, but also psycho-social outcomes, and generally to help them better integrate into society.


Assuntos
Transtornos Mentais/economia , Transtornos Mentais/reabilitação , Organizações sem Fins Lucrativos/economia , Parcerias Público-Privadas/economia , Reabilitação Vocacional/economia , Integração Comunitária , Análise Custo-Benefício , Humanos , Itália , Transtornos Mentais/psicologia , Organizações sem Fins Lucrativos/legislação & jurisprudência , Parcerias Público-Privadas/legislação & jurisprudência , Ajustamento Social , Populações Vulneráveis/legislação & jurisprudência , Populações Vulneráveis/psicologia , Avaliação da Capacidade de Trabalho
14.
Public Health Nutr ; 16(5): 815-23, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-23149122

RESUMO

OBJECTIVE: Little is known about how public entities can partner with industry to achieve public health goals. We investigated industry's perspective of factors that influenced their adoption and implementation of voluntary, government-issued nutrition guidelines (Alberta Nutrition Guidelines for Children and Youth, ANGCY) in recreational facilities. DESIGN: In-depth semi-structured interviews were conducted. Data were analysed using directed content analysis. SETTING: Food services in recreational facilities. SUBJECTS: Seven managers from industry participated; five from companies that had adopted and implemented the ANGCY (adopters) in recreational facilities and two from companies that had not (non-adopters). RESULTS: Industry views nutrition guidelines through the lens of profitability. Non-adopters were unwilling to implement the ANGCY for fear of sacrificing short-term profitability, whereas adopters adhered to them in an attempt to position themselves for long-term profitability. Adopters faced barriers including few resources, no training, complex guidelines, low availability of and demand for ANGCY-compliant products, competitive pressures and substantial declines in revenue. Managers believed widespread voluntary adoption of the ANGCY was unlikely without government incentives and/or a mandate, as the environmental context for voluntary action was poor. All managers supported government-mandated implementation of the ANGCY to level the playing field upon which companies compete. CONCLUSIONS: Public-private partnerships in recreational facilities can embrace public health goals in the short term, provided industry perceives potential for long-term financial gain. Widespread uptake of voluntary nutrition guidelines in this setting is unlikely, however, as market mechanisms do not encourage industry to sell and promote healthier options. Government legislation may therefore be warranted.


Assuntos
Serviços de Alimentação/normas , Guias como Assunto/normas , Política Nutricional/legislação & jurisprudência , Saúde Pública , Alberta , Capitalismo , Serviços de Alimentação/legislação & jurisprudência , Parcerias Público-Privadas/legislação & jurisprudência , Parcerias Público-Privadas/normas , Recomendações Nutricionais , Recreação
15.
J Interprof Care ; 26(2): 134-40, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22360392

RESUMO

Transformation in the structure and delivery of services for children and young people in the UK Children Act (Department for Education & Skills, 2004. The Children Act. London: HMSO) initiated new alliances between statutory, public and voluntary agencies. Traditional relationships and notions of partnership have been extended, necessitating an innovative approach to dialogue and multiple perspectives. Hudson's assertion that although the "rhetoric on partnering remains strong, the real policy thrust is now about choice and contestability" (2006, Journal of Integrated Care, 14(1), 13-21) exemplifies the dynamic policy context around notions of partnership and the rationale for collaborative advantage. This paper explores the experiences of practitioners working in a relatively new multi-agency context--the common assessment framework (CAF). Envisaged as a standardized approach to the assessment of need and as a tool to facilitate integrated working, the CAF is utilized by practitioners in the UK to improve outcomes for children and young people. We present data from a study that employed an interpretative phenomenological analysis approach and gathered semi-structured interviews with 20 practitioners. Interviews drew upon their experiences of interprofessional working in which diversity, partnership working, and competing aims and objectives emerged as significant themes. The insights that were gained are discussed in terms of their potential impact on service delivery in the UK and their contribution toward responsive practice across dynamic professional boundaries.


Assuntos
Atitude do Pessoal de Saúde , Serviços de Saúde da Criança/organização & administração , Relações Interprofissionais , Parcerias Público-Privadas/organização & administração , Instituições Filantrópicas de Saúde/organização & administração , Adulto , Criança , Serviços de Saúde da Criança/legislação & jurisprudência , Comportamento Cooperativo , Feminino , Humanos , Relações Interinstitucionais , Entrevistas como Assunto , Masculino , Pessoa de Meia-Idade , Parcerias Público-Privadas/legislação & jurisprudência , Pesquisa Qualitativa , Reino Unido , Instituições Filantrópicas de Saúde/legislação & jurisprudência
16.
J Transl Med ; 9: 16, 2011 Jan 27.
Artigo em Inglês | MEDLINE | ID: mdl-21272322

RESUMO

Recent advances in medical technology and key discoveries in biomedical research have the potential to improve human health in an unprecedented fashion. As a result, many of the Arab Gulf countries, particularly Qatar are devoting increasing resources toward establishing centers of excellence in biomedical research. However, there are challenges that must be overcome. The low profile of private medical institutions and their negligible endowments in the region are examples of such challenges. Business-type government controlled universities are not the solution for overcoming the challenges facing higher education and research programs in the Middle East.During the last decade, Qatar Foundation for Education, Science and Community Development has attracted six branch campuses of American Institutions of higher learning to the Education City in Qatar, a 2500-acre area, which is rapidly becoming a model of integrating higher education and research in the region. Not-for profit, time-tested education institutions from abroad in public-private partnership with local organizations offer favorable conditions to build robust research programs in the region. Weill Cornell Medical College in Qatar (WCMC-Q) of Cornell University is an example such an institution. It is the first and only medical school in Qatar.WCMC-Q's interwoven education, research and public health based framework lays a sturdy foundation for developing and implementing translational medicine research programs of importance to the State of Qatar and Middle Eastern nations. This approach is yielding positive results. Discoveries from this program should influence public policy in a positive fashion toward reducing premature mortality and morbidity due to diabetes, obesity, heart disease and cancer, examples of health conditions commonly encountered in Qatar.


Assuntos
Pesquisa Biomédica/educação , Pesquisa Biomédica/organização & administração , Educação Médica/organização & administração , Educação Médica/tendências , Pesquisa Translacional Biomédica/organização & administração , Pesquisa Biomédica/tendências , Meio Ambiente , Humanos , Oriente Médio , Modelos Biológicos , Parcerias Público-Privadas/legislação & jurisprudência , Parcerias Público-Privadas/organização & administração , Catar , Faculdades de Medicina/legislação & jurisprudência , Faculdades de Medicina/organização & administração
18.
LDI Issue Brief ; 17(2): 1-4, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22049582

RESUMO

The rate of new drug approvals in the US has remained essentially constant since 1950, while the costs of drug development have soared. Many commentators question the sustainability of the current model of drug development, in which large pharmaceutical companies incur markedly escalating costs to deliver the same number of products to market. This Issue Brief summarizes the problem, describes ongoing governmental efforts to influence the process, and suggests changes in regulatory science and translational medicine that may promote more successful development of safe and effective therapeutics


Assuntos
Comportamento Cooperativo , Aprovação de Drogas/legislação & jurisprudência , Descoberta de Drogas/métodos , Indústria Farmacêutica/métodos , Relações Interinstitucionais , Parcerias Público-Privadas/tendências , Ciência/métodos , Pesquisa Translacional Biomédica/métodos , Desenho de Fármacos , Descoberta de Drogas/economia , Descoberta de Drogas/legislação & jurisprudência , Descoberta de Drogas/tendências , Indústria Farmacêutica/economia , Indústria Farmacêutica/legislação & jurisprudência , Indústria Farmacêutica/tendências , Previsões , Regulamentação Governamental , Humanos , Disseminação de Informação , Modelos Organizacionais , National Institutes of Health (U.S.) , Preparações Farmacêuticas/economia , Setor Privado , Setor Público , Parcerias Público-Privadas/economia , Parcerias Público-Privadas/legislação & jurisprudência , Ciência/economia , Ciência/legislação & jurisprudência , Ciência/tendências , Pesquisa Translacional Biomédica/economia , Pesquisa Translacional Biomédica/legislação & jurisprudência , Pesquisa Translacional Biomédica/tendências , Estados Unidos , United States Food and Drug Administration , Universidades
19.
Can Public Adm ; 54(3): 377-98, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22165164

RESUMO

This article considers a coalition model of governance as an innovative approach to public management. In general, the coalition governance model adopts key principles of new public management and inherits criticisms similar to those levelled against the new managerialism. Looking at a case study of parent child coalitions in Manitoba, this article explores some benefits and consequences of implementing and utilizing coalition governance as a model for social policy. It finds that the attempt to increase child-centred programming across the province required innovative adjustments to the management of this social policy issue, as well as a restructuring of the overarching policy structure. Innovative public management and the implementation of a coalition governance approach helped transform early childhood development in Manitoba from a private and personal family concern to a public policy issue. It has increased citizen engagement and has also increased government access to a previously inaccessible segment of society. Although these innovations resolved some key concerns, additional criticisms remain as yet unaddressed.


Assuntos
Desenvolvimento Infantil , Educação , Governo , Política Pública , Parcerias Público-Privadas , Criança , Proteção da Criança/economia , Proteção da Criança/etnologia , Proteção da Criança/história , Proteção da Criança/legislação & jurisprudência , Proteção da Criança/psicologia , Educação/economia , Educação/história , Educação/legislação & jurisprudência , Governo/história , História do Século XX , História do Século XXI , Humanos , Manitoba/etnologia , Política Pública/economia , Política Pública/história , Política Pública/legislação & jurisprudência , Parcerias Público-Privadas/economia , Parcerias Público-Privadas/história , Parcerias Público-Privadas/legislação & jurisprudência
20.
J Asian Afr Stud ; 46(6): 546-66, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22213879

RESUMO

Poverty and food security are endemic issues in much of sub-Saharan Africa. To eradicate extreme poverty and hunger in the region remains a key Millennium Development Goal. Many African governments have pursued economic reforms and agricultural policy interventions in order to accelerate economic growth that reduces poverty faster. Agricultural policy regimes in Zambia in the last 50 years (1964­2008) are examined here to better understand their likely impact on food security and poverty, with an emphasis on the political economy of maize subsidy policies. The empirical work draws on secondary sources and an evaluation of farm household data from three villages in the Kasama District of Zambia from 1986/87 and 1992/93 to estimate a two-period econometric model to examine the impact on household welfare in a pre- and post-reform period. The analysis shows that past interventions had mixed effects on enhancing the production of food crops such as maize. While such reforms were politically popular, it did not necessarily translate into household-level productivity or welfare gains in the short term. The political economy of reforms needs to respond to the inherent diversity among the poor rural and urban households. The potential of agriculture to generate a more pro-poor growth process depends on the creation of new market opportunities that most benefit the rural poor. The state should encourage private sector investments for addressing infrastructure constraints to improve market access and accelerate more pro-poor growth through renewed investments in agriculture, rural infrastructure, gender inclusion, smarter subsidies and regional food trade. However, the financing of such investments poses significant challenges. There is a need to address impediments to the effective participation of public private investors to generate more effective poverty reduction and hunger eradication programmes. This article also explores the opportunities for new public­private investments through South­South cooperation and Asia-driven growth for reducing poverty in Zambia.


Assuntos
Economia , Abastecimento de Alimentos , Grupos Populacionais , Pobreza , Inanição , Zea mays , África Subsaariana/etnologia , Economia/história , Economia/legislação & jurisprudência , Abastecimento de Alimentos/economia , Abastecimento de Alimentos/história , História do Século XX , História do Século XXI , Humanos , Fome/etnologia , Fome/fisiologia , Grupos Populacionais/educação , Grupos Populacionais/etnologia , Grupos Populacionais/história , Grupos Populacionais/legislação & jurisprudência , Grupos Populacionais/psicologia , Pobreza/economia , Pobreza/etnologia , Pobreza/história , Pobreza/legislação & jurisprudência , Pobreza/psicologia , Parcerias Público-Privadas/economia , Parcerias Público-Privadas/história , Parcerias Público-Privadas/legislação & jurisprudência , Mudança Social/história , Problemas Sociais/economia , Problemas Sociais/etnologia , Problemas Sociais/história , Problemas Sociais/legislação & jurisprudência , Problemas Sociais/psicologia , Responsabilidade Social , Inanição/economia , Inanição/etnologia , Inanição/história , Inanição/psicologia , Zâmbia/etnologia , Zea mays/economia , Zea mays/história
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA